New Trends in Esophageal Cancer Management
- PMID: 34204314
- PMCID: PMC8235022
- DOI: 10.3390/cancers13123030
New Trends in Esophageal Cancer Management
Abstract
Esophageal cancer (EC) is a condition with a five-year survival rate of around 15% for all stages considered [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Shapiro J., van Lanschot J.J.B., Hulshof M.C.C.M., van Hagen P., van Berge Henegouwen M.I., Wijnhoven B.P.L., van Laarhoven H.W.M., Nieuwenhuijzen G.A.P., Hospers G.A.P., Bonenkamp J.J., et al. Neoadjuvant Chemoradiotherapy plus Surgery versus Surgery Alone for Oesophageal or Junctional Cancer (CROSS): Long-Term Results of a Randomised Controlled Trial. Lancet Oncol. 2015;16:1090–1098. doi: 10.1016/S1470-2045(15)00040-6. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
